Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry
Joyce Wing Yan Mak, Carmen Lok Tung Ho, Kylie Wong, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 3, pp. 401-408
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
Sara Jarmakiewicz-Czaja, Magdalena Zielińska, Aneta Sokal, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2388-2388
Open Access | Times Cited: 56
Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last
Catherine Le Berre, Amanda Ricciuto, Laurent Peyrin‐Biroulet, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1424-1438
Closed Access | Times Cited: 43
Management of inflammatory bowel diseases in older adults
Siddharth Singh, Brigid S. Boland, Tine Jess, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 4, pp. 368-382
Open Access | Times Cited: 37
Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease
Han Zhang, Rahul Kalla, Jie Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Editorial: Can We Prevent Inflammatory Bowel Disease?
Agnes Hiu Yan Ho, Joyce Wing Yan Mak
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study
Guanghui Cui, Shaojie Li, Hui Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Can we change the natural course of inflammatory bowel disease?
Catherine Le Berre, Silvio Danese, Laurent Peyrin‐Biroulet
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 21
Management of inflammatory bowel disease in the elderly: A review
Paula Sousa, Lorenzo Bertani, Cláudio Rodrigues
Digestive and Liver Disease (2023) Vol. 55, Iss. 8, pp. 1001-1009
Open Access | Times Cited: 15
Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries—A nationwide cohort study
Bente Mertz Nørgård, Floor Dijkstra Zegers, Torben Knudsen, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 1, pp. 48-59
Open Access | Times Cited: 13
Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
Rie Louise Møller Nordestgaard, Mads Damsgaard Wewer, Mikkel Malham, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 4, pp. 457-468
Open Access | Times Cited: 5
Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000–2021
Pojsakorn Danpanichkul, Yanfang Pang, Chawinthorn Vuthithammee, et al.
Digestive Diseases and Sciences (2025)
Closed Access
The role of the three major intestinal barriers in ulcerative colitis in the elderly
Min Fu, Qiwen Wang, Yaru Liu, et al.
Ageing Research Reviews (2025), pp. 102752-102752
Closed Access
Epidemiology and temporal trends of adult inflammatory bowel disease in Taiwan: Multicenter study from the TSIBD registration
Chih-Wen Huang, Shu–Chen Wei, Ming‐Jium Shieh, et al.
Journal of the Formosan Medical Association (2025)
Open Access
Frailty is a stronger predictor than age for postoperative morbidity in Crohn’s disease
Joshua H. Wolf, Tarek Hassab, Christopher R. D’Adamo, et al.
Surgery (2021) Vol. 170, Iss. 4, pp. 1061-1065
Closed Access | Times Cited: 24
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 11, pp. 867-878
Closed Access | Times Cited: 18
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?
Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 441-452
Open Access | Times Cited: 16
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study
Tamás Resál, P Bacsúr, Csilla Keresztes, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 768-779
Open Access | Times Cited: 10
The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management
Simon Hong, Seymour Katz
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 23
Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank
Shanshan Wu, Si-An Xie, Changzheng Yuan, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 3, pp. 384-395
Closed Access | Times Cited: 15
Editorial: Treatments for inflammatory bowel disease across the age spectrum—Are they the same?
Agnes Hiu Yan Ho, Joyce Wing Yan Mak
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 4, pp. 523-524
Closed Access | Times Cited: 2
The Incidence Rate and Risk Factors of Malignancy in Elderly-Onset Inflammatory Bowel Disease: A Chinese Cohort Study From 1998 to 2020
Zheng Wang, Huimin Zhang, Hong Yang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
Seth R. Shaffer, M Ellen Kuenzig, Joseph W. Windsor, et al.
Journal of the Canadian Association of Gastroenterology (2023) Vol. 6, Iss. Supplement_2, pp. S45-S54
Open Access | Times Cited: 5
New Surgery and Hospital-diagnosed Infections in Elderly Patients with Inflammatory Bowel Disease Undergoing Surgery: A Nationwide Cohort Study
Bente Mertz Nørgård, Olav Sivertsen Garvik, Floor Dijkstra Zegers, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 9, pp. 1406-1414
Closed Access | Times Cited: 1
Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade
Sahana Shankar, Snehali Majumder, Suparna Mukherjee, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Clinical Characteristics and Long-term Prognosis of Elderly-Onset Ulcerative Colitis in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea
Sang Hyoung Park, Seung Kyu Jeong, Ji Hyun Lee, et al.
Gut and Liver (2021) Vol. 15, Iss. 5, pp. 742-751
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top